相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prevalence of anti-nuclear autoantibodies in subjects exposed to natural asbestiform fibers: a cross-sectional study
Caterina Ledda et al.
JOURNAL OF IMMUNOTOXICOLOGY (2018)
Biomarkers in mesothelioma
David T. Arnold et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2018)
Recent Advances in the Diagnosis of Malignant Mesothelioma: Focus on Approach in Challenging Cases and in Limited Tissue and Cytologic Samples
Sara Monaco et al.
ADVANCES IN ANATOMIC PATHOLOGY (2018)
Occupational exposure to fluoro-edenite and prevalence of anti-nuclear autoantibodies
Venerando Rapisarda et al.
FUTURE ONCOLOGY (2018)
Fibulin-3 immunoexpression in malignant mesothelioma due to fluoro-edenite: a preliminary report
Rosario Caltabiano et al.
FUTURE ONCOLOGY (2018)
Expression analysis of HMGB1 in histological samples of malignant pleural mesothelioma
Eltjona Rrapaj et al.
HISTOPATHOLOGY (2018)
Immunohistochemical Expression of Aquaporin-1 in Fluoro-Edenite-Induced Malignant Mesothelioma: A Preliminary Report
Giuseppe Angelico et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Secreted and Tissue miRNAs as Diagnosis Biomarkers of Malignant Pleural Mesothelioma
Vanessa Martinez-Rivera et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Analysis of fibulin-3 after exposure to asbestos-like fibers
Venerando Rapisarda et al.
ENVIRONMENTAL RESEARCH (2017)
The Effect of Aquaporin 1-Inhibition on Vasculogenic Mimicry in Malignant Mesothelioma
Emily Pulford et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Immunomodulatory effects in workers exposed to naturally occurring asbestos fibers
Caterina Ledda et al.
MOLECULAR MEDICINE REPORTS (2017)
miRNA regulation is important for DNA damage repair and recognition in malignant pleural mesothelioma
Fabian Dominik Mairinger et al.
VIRCHOWS ARCHIV (2017)
Diagnostic and prognostic utilities of humoral fibulin-3 in malignant pleural mesothelioma: Evidence from a meta-analysis
Dongxu Pei et al.
ONCOTARGET (2017)
Prognostic significance of soluble mesothelin in malignant pleural mesothelioma: a meta-analysis
Long Tian et al.
ONCOTARGET (2017)
Targeting microRNA to improve diagnostic and therapeutic approaches for malignant mesothelioma
Kimberly A. Birnie et al.
ONCOTARGET (2017)
Downregulation of miR-99a/let-7c/miR-125b miRNA cluster predicts clinical outcome in patients with unresected malignant pleural mesothelioma
Anna Truini et al.
Oncotarget (2017)
Association of Asbestos Exposure With Malignant Mesothelioma Incidence in Eastern China
Weimin Mao et al.
JAMA ONCOLOGY (2017)
Plasmatic extracellular vesicle microRNAs in malignant pleural mesothelioma and asbestos-exposed subjects suggest a 2-miRNA signature as potential biomarker of disease
Tommaso Cavalleri et al.
PLOS ONE (2017)
Deregulation of miRNAs in malignant pleural mesothelioma is associated with prognosis and suggests an alteration of cell metabolism
Chiara De Santi et al.
SCIENTIFIC REPORTS (2017)
MicroRNA Expression in Malignant Pleural Mesothelioma and Asbestosis: A Pilot Study
Paola Mozzoni et al.
DISEASE MARKERS (2017)
Serum HMGB1 as a Potential Biomarker for Patients with Asbestos-Related Diseases
Shibo Ying et al.
DISEASE MARKERS (2017)
Comparison of the Diagnostic Performance of Fibulin-3 and Mesothelin in Patients with Pleural Effusions from Malignant Mesothelioma
Enrico Battolla et al.
ANTICANCER RESEARCH (2017)
Midkine is a potential novel marker for malignant mesothelioma with different prognostic and diagnostic values from mesothelin
Guntulu Ak et al.
BMC CANCER (2017)
Malignant Pleural Mesothelioma: The Need to Move from Research to Clinical Practice
Caterina Ledda et al.
ARCHIVES OF MEDICAL RESEARCH (2016)
HMGB1 and Its Hyperacetylated Isoform are Sensitive and Specific Serum Biomarkers to Detect Asbestos Exposure and to Identify Mesothelioma Patients (Publication with Expression of Concern. See vol. 26, pg. 1529, 2020)
Andrea Napolitano et al.
CLINICAL CANCER RESEARCH (2016)
Sheep lymph-nodes as a biological indicator of environmental exposure to fluoro-edenite
Caterina Ledda et al.
ENVIRONMENTAL RESEARCH (2016)
Natural carcinogenic fiber and pleural plaques assessment in a general population: A cross-sectional study
Caterina Ledda et al.
ENVIRONMENTAL RESEARCH (2016)
Mesothelial cells and peritoneal homeostasis
Steven Eugene Mutsaers et al.
FERTILITY AND STERILITY (2016)
High risk of pleural plaques and parenchymal abnormalities in women living in Biancavilla (Italy)
Caterina Ledda et al.
FUTURE ONCOLOGY (2016)
Early effects of fluoro-edenite: correlation between IL-18 serum levels and pleural and parenchymal abnormalities
Caterina Ledda et al.
FUTURE ONCOLOGY (2016)
Asbestos exposure and histological subtype of malignant mesothelioma
P. Franklin et al.
OCCUPATIONAL AND ENVIRONMENTAL MEDICINE (2016)
HMGB1 overexpression as a prognostic factor for survival in cancer: a meta-analysis and systematic review
Tengyun Wu et al.
ONCOTARGET (2016)
Diagnostic value of fibulin-3 for malignant pleural mesothelioma: A systematic review and meta-analysis
Ran Ren et al.
ONCOTARGET (2016)
Usefulness of Aquaporin 1 as a Prognostic Marker in a Prospective Cohort of Malignant Mesotheliomas
Jack Driml et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Fibulin-3 as a Diagnostic Biomarker in Patients with Malignant Mesothelioma
Halide Kaya et al.
Asian Pacific Journal of Cancer Prevention (2015)
Fibulin-3 levels in malignant pleural mesothelioma are associated with prognosis but not diagnosis
Michaela B. Kirschner et al.
BRITISH JOURNAL OF CANCER (2015)
Comparison of mesothelin and fibulin-3 in pleural fluid and serum as markers in malignant mesothelioma
Jenette Creaney et al.
CURRENT OPINION IN PULMONARY MEDICINE (2015)
Blockade of Aquaporin 1 Inhibits Proliferation, Motility, and Metastatic Potential of Mesothelioma In Vitro but not in an In Vivo Model
Sonja Klebe et al.
DISEASE MARKERS (2015)
FBLN-3 as a biomarker of pleural plaques in workers occupationally exposed to carcinogenic fibers: a pilot study
Venerando Rapisarda et al.
FUTURE ONCOLOGY (2015)
BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations
Marta Cigognetti et al.
MODERN PATHOLOGY (2015)
Prognostic value of several biomarkers for the patients with malignant pleural mesothelioma
Hui Liu et al.
TUMOR BIOLOGY (2015)
Detection of pleural plaques in workers exposed to inhalation of natural fluoro-edenite fibres
Venerando Rapisarda et al.
ONCOLOGY LETTERS (2015)
Two Different Serum MiRNA Signatures Correlate with the Clinical Outcome and Histological Subtype in Pleural Malignant Mesothelioma Patients
Monica Lamberti et al.
PLOS ONE (2015)
Fibulin-3 as a biomarker of response to treatment in malignant mesothelioma
Viljem Kovac et al.
RADIOLOGY AND ONCOLOGY (2015)
Diagnostic accuracy of osteopontin for malignant pleural mesothelioma: A systematic review and meta-analysis
Zhi-De Hu et al.
CLINICA CHIMICA ACTA (2014)
Significance of osteopontin in the sensitivity of malignant pleural mesothelioma to pemetrexed
Susumu Takeuchi et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
The value of inflammatory parameters in the prognosis of malignant mesothelioma
Ozlem Abakay et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2014)
Is Soluble Mesothelin-Related Protein an Upfront Predictive Marker of Pleural Mesothelioma? A Prospective Study on Italian Workers Exposed to Asbestos
Rosa Filiberti et al.
ONCOLOGY (2014)
Comparison of fibulin-3 and mesothelin as markers in malignant mesothelioma
Jenette Creaney et al.
THORAX (2014)
Prognostic factors affecting survival in malignant pleural mesothelioma: analysis of 125 subjects
Berna Komurcuoglu et al.
TUMORI (2014)
Reproducibility of histological subtyping of malignant pleural mesothelioma
Luka Brcic et al.
VIRCHOWS ARCHIV (2014)
The Global Spread of Asbestos
Arthur L. Frank et al.
ANNALS OF GLOBAL HEALTH (2014)
Effect of Asbestos Exposure on Differentiation of Cytotoxic T Lymphocytes in Mixed Lymphocyte Reaction of Human Peripheral Blood Mononuclear Cells
Naoko Kumagai-Takei et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2013)
Serum HMGB1 as a prognostic marker for malignant pleural mesothelioma
Chiharu Tabata et al.
BMC CANCER (2013)
Gene expression profile of aquaporin 1 and associated interactors in malignant pleural mesothelioma
Rajesh Jagirdar et al.
GENE (2013)
Aquaporin 1 is an independent prognostic factor in pleural malignant mesothelioma
Steven Chuan-Hao Kao et al.
CANCER (2012)
Cancer Cell Secretion of the DAMP Protein HMGB1 Supports Progression in Malignant Mesothelioma
Sandro Jube et al.
CANCER RESEARCH (2012)
Soluble mesothelin-related peptides levels in patients with malignant mesothelioma
Alenka Franko et al.
DISEASE MARKERS (2012)
Genomic gains and losses in malignant mesothelioma demonstrated by FISH analysis of paraffin-embedded tissues
Maiko Takeda et al.
JOURNAL OF CLINICAL PATHOLOGY (2012)
The first discovered water channel protein, later called aquaporin 1: Molecular characteristics, functions and medical implications
Gheorghe Benga
MOLECULAR ASPECTS OF MEDICINE (2012)
Fibulin-3 as a Blood and Effusion Biomarker for Pleural Mesothelioma
Harvey I. Pass et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Identification of miRNA-103 in the Cellular Fraction of Human Peripheral Blood as a Potential Biomarker for Malignant Mesothelioma - A Pilot Study
Daniel G. Weber et al.
PLOS ONE (2012)
Resistance to asbestos-induced apoptosis with continuous exposure to crocidolite on a human T cell
Megumi Maeda et al.
SCIENCE OF THE TOTAL ENVIRONMENT (2012)
Pleural Mesothelioma in New Caledonia: Associations with Environmental Risk Factors
Francine Baumann et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2011)
Accuracy of Diagnostic Biopsy for the Histological Subtype of Malignant Pleural Mesothelioma
Steven Chuan-Hao Kao et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
MicroRNAs Dysregulation in Human Malignant Pleural Mesothelioma
Veronica Balatti et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Diagnostic Performance of Soluble Mesothelin and Megakaryocyte Potentiating Factor in Mesothelioma
Kevin Hollevoet et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Soluble mesothelin related peptides (SMRP) and osteopontin as protein biomarkers for malignant mesothelioma: analytical validation of ELISA based assays and characterization at mRNA and protein levels
Alex J. Rai et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2010)
THE ROLE OF PERITONEAL LAVAGE AND THE PROGNOSTIC SIGNIFICANCE OF MESOTHELIAL CELL AREA IN PREVENTING ENCAPSULATING PERITONEAL SCLEROSIS
Tadashi Yamamoto et al.
PERITONEAL DIALYSIS INTERNATIONAL (2010)
Translational therapies for malignant pleural mesothelioma
Carmen Belli et al.
Expert Review of Respiratory Medicine (2010)
Serum mesothelin has a higher diagnostic utility than hyaluronic acid in malignant mesothelioma
Bogdan Grigoriu et al.
CLINICAL BIOCHEMISTRY (2009)
Serum and pleural fluid biomarkers for mesothelioma
Jenette Creaney et al.
CURRENT OPINION IN PULMONARY MEDICINE (2009)
Pathogenesis of malignant pleural mesothelioma and the role of environmental and genetic factors
Shoshana J. Weiner et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2009)
Osteopontin is not a specific marker in malignant pleural mesothelioma
Laura Paleari et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2009)
Prognostic role of osteopontin expression in malignant pleural mesothelioma
Susanna Cappia et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2008)
Risk factors for major complications after extrapleural pneumonectomy for malignant pleural mesothelioma
Marc de Perrot et al.
ANNALS OF THORACIC SURGERY (2008)
Mesothelioma Epidemiology, Carcinogenesis, and Pathogenesis
Haining Yang et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2008)
Diagnostic and Prognostic Value of Soluble Mesothelin-Related Proteins in Patients with Malignant Pleural Mesothelioma in Comparison with Benign Asbestosis and Lung Cancer
Joachim Schneider et al.
JOURNAL OF THORACIC ONCOLOGY (2008)
Environmental mesothelioma associated with tremolite asbestos: Lessons from the experiences of Turkey, Greece, Corsica, New Caledonia and Cyprus
Stavros H. Constantopoulos
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2008)
Biomarkers for mesothelioma
Arnaud Scherpereel et al.
CURRENT OPINION IN PULMONARY MEDICINE (2007)
Utility of osteopontin and serum mesothelin in malignant pleural mesothelioma diagnosis and prognosis assessment
Bogdan-Dragos Grigoriu et al.
CLINICAL CANCER RESEARCH (2007)
Detection of malignant mesothelioma in asbestos-exposed individuals: The potential role of soluble mesothelin-related protein
J Creaney et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2005)
Asbestos exposure, pleural mesothelioma, and serum osteopontin levels
HI Pass et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Medical progress - Advances in malignant mesothelioma
BWS Robinson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Humoral immune response to mesothelin in mesothelioma and ovarian cancer patients
M Ho et al.
CLINICAL CANCER RESEARCH (2005)
Monitoring of fluoro-edenite fibre pollution through the study of sheep lymph nodes as a model of a biological indicator
V Rapisarda et al.
OCCUPATIONAL AND ENVIRONMENTAL MEDICINE (2005)
Characterization of amphibole fibres linked to mesothelioma in the area of Biancavilla, Eastern Sicily, Italy
A Gianfagna et al.
MINERALOGICAL MAGAZINE (2003)
Environmental malignant mesothelioma in southern Anatolia:: A study of fifty cases
EH Zeren et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2000)
分享论文
